[Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects; D004285:Dogs; D018492:Dopamine Antagonists; D004347:Drug Interactions; D006613:Higher Nervous Activity / Q000187:drug effects; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology; D011954:Receptors, Dopamine / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D000262:Adenylyl Cyclases
Zavisimost' antipsikhoticheskogo éffekta neĭroleptikov ot ikh dofaminoblokiruiushchikh svoĭstv.